CTRI/2012/07/002802进行中（未招募）3 期
A Randomized Controlled Trial of Neoadjuvant Weekly Paclitaxel versus Weekly Paclitaxel Plus Weekly Carboplatin In Women with Triple Negative Breast Cancer
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Age 18-70 years
- •2.All women patients with triple negative hormone status
- •planned for neoadjuvant chemotherapy
- •3.Patients with adequate baseline marrow function defined as
- •ANC > 1500/mm3 and Platelet count > 1, 00,000/mm3.
- •4.Patients with acceptable liver function tests (normal bilirubin and AST/ALT < 2 times the upper limit of normal) and normal renal function tests at baseline
- •5.Patients willing to provide informed consent
- •6.Patients fit for chemotherapy
排除标准
- •1. Prior excision biopsy
- •2. Metastatic breast cancer
- •3. Women with inflammatory breast cancer
- •4. Poor cardiac function at baseline with LVEF <40%
- •5. Patients with a prior history of a malignancy
- •6. Pregnant or lactating women.
研究者
相似试验
已完成
1 期
eo-adjuvant Progesterone and Vitamin D3 in Breast cancerCTRI/2013/06/003788Tata Memorial Hospital800
进行中（未招募）
1 期
Randomized Controlled Trial comparing two groups of Patients with High-Risk, Localized Soft Tissue Sarcoma of the Extremity: the first one receiving Neoadjuvant Pembrolizumab with Radiotherapy and Adjuvant Pembrolizumab after surgery, and the second one receiving Radiotherapy and surgery, aiming to assess the safety and efficacy profile of PembrolizumabThis trial investigates whether neoadjuvant radiotherapy combined with pembrolizumab followed by surgical resection and adjuvant pembrolizumab improves disease-free survival for patients with high-risk soft tissue sarcoma of the extremity (undifferentiated pleomorphic sarcoma or dedifferentiated/pleomorphic liposarcoma, tumor size > 5 cm, grade 2 or 3 out of 3) compared to radiotherapy alone followed by surgical resectionMedDRA version: 20.0Level: PTClassification code 10024629Term: Liposarcoma metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: HLTClassification code 10041298Term: Soft tissue sarcomas histology unspecifiedSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-001360-39-ITSARC110
已完成
3 期
Randomized controlled trial of neoadjuvant chemotherapy plus surgery versus neoadjuvant chemoradiotherapy plus surgery in patients with clinical stage IIB-III esophageal carcinoma (Subset analyses depending on the REG I expression in the tumor)thoracic esophageal cancerJPRN-UMIN000004707The cancer board of esophageal cancer in Akita University Hospital150
招募中
3 期
a phase 3 study of chemotherapy folowed by surgery and postoperative chemotherapy compared to initial surgery followed by chemotherapy in advanced ovarian cancerCTRI/2014/01/004363Sri Venkateswara Institute of Medical Sciences60
已完成
2 期
Randomized Phase II trial of Neoadjuvant weekly Nab-paclitaxel followed by FEC compared with Docetaxel followed by FEC for early breast cancerBreast CancerJPRN-UMIN000005388Department of Breast Surgical Oncology, Showa University150